- Direction
- Unknown
- Own history
- —
- Peers
- 87th
- Persistence
- TRANSIENT
· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTPicard Medical, Inc.'s latest supported as-filed period reports revenue of $3.0M, 38.6% above the comparable as-filed period; gross margin moved 2681 basis points higher on the same comparison basis. Every value below links to its SEC accession and metric lineage.
Separate current dimensions—not a universal score or investment ranking.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 3 independently calculated changes: Revenue increased 38.6%; Operating margin moved 852 bp higher; Operating income decreased 31.5%.
3 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 38.6%; Operating margin moved 852 bp higher; Operating income decreased 31.5%.
3 evidence-backed componentsOperating income changed -31.5% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
PMI · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001437749-26-033423SEC ↗8-KOct 13, 2026Period Oct 7, 20260001437749-26-032542SEC ↗8-KOct 6, 2026Period Sep 30, 20260001437749-26-032125SEC ↗8-KAug 20, 2026Period Aug 19, 20260001437749-26-028585SEC ↗10-QAug 19, 2026Period Jun 30, 20260001437749-26-028565SEC ↗8-KJul 27, 2026Period Jul 22, 20260001437749-26-024465SEC ↗8-KJul 22, 2026Period Jul 21, 20260001437749-26-024025SEC ↗GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Operating margin changed +852 basis points from the comparable as-filed period.
Gross margin changed +2681 basis points from the comparable as-filed period.
Revenue changed +38.6% from the comparable as-filed period.
Research & development changed +84.9% from the comparable as-filed period.
Cash & equivalents changed -90.7% from the comparable as-filed period.
Current liabilities changed -83.7% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001437749-26-023932